Israeli Prime Minister Benjamin Netanyahu has vowed to press ahead with his contentious judicial overhaul, despite unprecedented mass protests at home, growing defections by military reservists and appeals from the U.S. president to put the plan on hold

This summer’s sweltering heat has put tremendous stress on Texas’ power grid, with the state setting 10 new records for electricity demand

A high-stakes lawsuit over the future of a widely used abortion drug is likely heading to the US Supreme Court, set to determine the fate of abortion rights access across the country for a second time within two years. Three Republican-appointed judges on a federal appeals court have determined that the federal government did not follow proper procedures when it amended regulations for a commonly used medication abortion drug in 2016. But the restrictions will not immediately take effect. The panel partially upheld a ruling from a Donald Trump-appointed federal judge in Texas, whose sweeping decision earlier this year threatened to strip access to the drug altogether. Nothing in the ruling from a three-judge panel on 16 August will go into effect until the nation’s highest court weighs in. Wednesday’s ruling argues that the US Food and Drug Administration unlawfully expanded access to mifepristone, which was first approved by the federal government more than 20 years ago. Mifepristone was first approved by the FDA in 2000 and is approved for use up to 10 weeks of pregnancy. A vast majority of abortions occur within the first nine weeks of pregnancy. From 2019 through 2020, nearly 93 per cent of all abortions were performed before the 13th week, according to the US Centers for Disease Control and Prevention. The drug – part of a two-drug protocol for medication abortions, the most common form of abortion care in the US – is the subject of a lawsuit from a group of anti-abortion activists represented by right-wing Christian legal group Alliance Defending Freedom, which joined efforts to overturn Roe v Wade at the Supreme Court last year. In April, US District Judge Matthew Kacsmaryk – a former right-wing activist lawyer who was appointed to the federal judiciary by Mr Trump – issued a ruling to suspend the FDA’s approval, which was immediately challenged by abortion rights advocates, providers, major medical groups, drug manufacturers and President Joe Biden’s administration. An initial ruling at the US Court of Appeals for the Fifth Circuit blocked part of that decision but struck down policies for mail-in prescriptions and rules that expanded the drug’s approval for pregnancies up to 10 weeks. On 21 April, the Supreme Court blocked the lower courts’ rulings from taking effect while the case plays out, retaining the status quo while the legal case plays out. Following the Supreme Court’s conservative supermajority decision to revoke a constitutional right to abortion care in Dobbs v Jackson Women’s Health Organization, at least 15 states – mostly across the US South – have effectively banned most abortions and imposed criminal penalties against providers. Abortion rights advocates and providers have warned that eliminating or restricting access to mifepristone could drastically impact an already-fragile landscape for abortion care. A ruling that undermines the FDA’s drug approval process could also open the door for other activist-driven legal battles over other drugs wrapped up in political debates, potentially inviting other destabilising lawsuits to Covid-19 vaccines, contraception, HIV medication, gender-affirming care, and other life-saving drugs. Read More What is mifepristone? The widely used pill in the abortion rights battle at the Supreme Court Abortion rights advocates win major victory in Ohio as voters reject GOP plan to thwart ballot measure Texas women detailed agonising pregnancies after being denied abortions. The state blames doctors Some abortion drug restrictions upheld by in a case bound for Supreme Court Akram criticizes Pakistan Cricket Board for leaving Imran Khan out of Independence Day video Netanyahu voices support for Israel's military after his allies and son lambaste security officials

Katy Perry appears to be promoting a career away from 'American Idol' and recently sang at King Charles III's coronation

A suicide occurs once every 11 minutes. Recognize the warning signs and see how to get help. Free 24-hour help is available.

SHANGHAI/BEIJING China's currency regulators have in recent weeks asked some commercial banks to reduce or delay their dollar

WASHINGTON U.S. President Joe Biden said on Thursday he had asked Acting Labor Secretary Julie Su to issue

Federal regulators on Thursday launched a legal attack on Microsoft’s proposed $69 billion takeover of video game maker Activision Blizzard by depicting it as an anticompetitive weapon while Microsoft hailed the deal as a way to make popular games such as Call of Duty more widely available at cheaper prices

Polish Prime Minister Mateusz Morawiecki has offered his conservative government’s resignation

Fashion designer Bobby Vaughn is in legal trouble after he was arrested at his girlfriend Libbie Mugrabi's opulent Manhattan townhouse

As UK will ban American bullys by the end of 2023, some experts said the decision may be moot as it was very diffcult to define the breed

Candance Owens claimed on her podcast that Carlee Russell 'should spend some time in prison'